drugset / Trial / NCT00968396

Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts

NCT00968396 ↗

Phase 2 Withdrawn M.D. Anderson Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to learn if cleaning the stem cells of a patient who has multiple myeloma (MM) with the bone marrow of a relative will make a cell product capable of replacing the bone marrow after standard treatment with chemotherapy.

Timeline

Start
2013-02
Primary completion
2015-02
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Melphalan Small molecule 100 mg/m2 Intravenous

Indications